Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Fitoterapia ; 155: 105058, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34637887

RESUMEN

The skin barrier prevents moisture evaporation and the entry of foreign substances such as allergens. Ceramides are one of the most important factors for maintaining skin barrier function. Melia toosendan is a plant of the Meliaceae family, and its fruit extracts have been used in Traditional Chinese Medicine as analgesics and anthelmintics; however, its ability to increase ceramide levels has not been reported. In this study, we screened for compounds present in M. toosendan fruit extracts that increase ceramide levels in the skin. We fractionated the extracts based on their activity to identify the active components. Nimbolinins, limonoids such as toosendanin, and hydroxylated unsaturated fatty acids were found to be the major active components. The structure-activity relationship of toosendanin derivatives indicated that the sites around R4 and R5 contributed to the activity. To the best of our knowledge, this is the first report showing that limonoids promote ceramide production in skin cells. Therefore, M. toosendan fruit extracts may be used to develop products for improving the skin barrier function.


Asunto(s)
Ceramidas/biosíntesis , Ácidos Grasos Insaturados/farmacología , Queratinocitos/metabolismo , Limoninas/farmacología , Melia/química , Células Cultivadas , Medicamentos Herbarios Chinos , Frutas/química , Humanos , Japón , Estructura Molecular , Relación Estructura-Actividad
2.
BMC Neurol ; 19(1): 182, 2019 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-31375081

RESUMEN

BACKGROUND: Hypothalamic lesions, such as tumors and demyelinating diseases, reportedly cause abnormal sleepiness. However, stroke involving the hypothalamus has rarely been described. Here, we report a patient with infarction restricted to the hypothalamus who presented with sudden onset of sleep. CASE PRESENTATION: A 42-year-old woman with a history of migraine without aura presented with irresistible sleepiness and developed several episodes of sudden onset of sleep. Neurological examinations were unremarkable except for partial left Horner syndrome. Brain magnetic resonance imaging (MRI) revealed a high-intensity lesion restricted to the left hypothalamus on diffusion-weighted and fluid-attenuated inversion recovery MRI images. Cerebrospinal fluid (CSF) orexin-A levels obtained on hospital day 3 after her sleepiness had resolved were normal (337 pg/mL; normal > 200 pg/mL). Serum anti-nuclear and anti-aquaporin 4 (AQP4) antibodies and CSF myelin basic protein and oligoclonal band were negative. A small hypothalamic infarction was suspected, and the patient was treated with intravenous edaravone and argatroban, as well as oral clopidogrel. Three months later, there had been no clinical relapse, and the hypothalamic lesion had almost disappeared on follow-up MRI. No new lesion suggestive of demyelinating disease or tumor was observed. CONCLUSION: Hypothalamic stroke should be considered a cause of sudden onset of sleep.


Asunto(s)
Infarto Encefálico/diagnóstico por imagen , Trastornos de Somnolencia Excesiva/etiología , Enfermedades Hipotalámicas/diagnóstico por imagen , Adulto , Acuaporina 4/inmunología , Infarto Encefálico/sangre , Infarto Encefálico/complicaciones , Femenino , Humanos , Enfermedades Hipotalámicas/sangre , Enfermedades Hipotalámicas/complicaciones , Hipotálamo , Infarto , Imagen por Resonancia Magnética , Proteína Básica de Mielina/sangre , Neuroimagen , Orexinas/líquido cefalorraquídeo , Sueño
3.
Dent Mater ; 26(1): 29-34, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19748664

RESUMEN

UNLABELLED: Ammonium hexafluorosilicate [SiF: (NH(4))(2)SiF(6)] was prepared in order to overcome the tooth discoloration caused by diamine silver fluoride [AgF: (NH(3))(2)AgF] application. We employed a single concentration of SiF solution in our previous study; therefore, it is still unclear how the concentration of SiF solution affects the occlusion of dentin tubules and composition of the precipitate. OBJECTIVE: The aim of this study was to evaluate the effects of changing the concentration of SiF on its clinical use as a dentin hypersensitivity treatment. METHODS: To simulate dentin tubules subject to dentin hypersensitivity, dentin disks were treated with EDTA for 2 min. Then, the disks were treated with several concentrations of SiF solution (from 100 to 19,400 ppm) for 3 min. The occlusion of dentin tubules was evaluated using scanning electron microscopy (SEM), and the composition of the precipitate formed in the tubules after SiF treatment was assessed using energy dispersive X-ray analysis (EDXA). RESULTS: SEM photographs demonstrated that dentin tubules after treatment with SiF were occluded homogeneously and fully regardless of the concentration of SiF solution. The Ca/P molar ratio of the precipitate formed in dentin tubules after SiF treatment was increased with the concentration of SiF solution. SIGNIFICANCE: It was concluded that the capacity to occlude dentin tubules was the same regardless of the concentration of SiF solution. However, the composition of the precipitate formed in the tubules was dependent on the concentration of SiF solution.


Asunto(s)
Desensibilizantes Dentinarios/administración & dosificación , Dentina/efectos de los fármacos , Fluoruros/administración & dosificación , Compuestos de Amonio Cuaternario/administración & dosificación , Ácido Silícico/administración & dosificación , Compuestos de Amonio , Calcio/análisis , Precipitación Química , Dentina/ultraestructura , Desensibilizantes Dentinarios/efectos adversos , Desensibilizantes Dentinarios/química , Permeabilidad de la Dentina/efectos de los fármacos , Sensibilidad de la Dentina/tratamiento farmacológico , Microanálisis por Sonda Electrónica , Fluoruros/química , Fluoruros/uso terapéutico , Fluoruros Tópicos , Humanos , Concentración de Iones de Hidrógeno , Ensayo de Materiales , Microscopía Electrónica de Rastreo , Fósforo/análisis , Compuestos de Amonio Cuaternario/efectos adversos , Compuestos de Amonio Cuaternario/química , Ácido Silícico/química , Compuestos de Silicona/química , Compuestos de Silicona/uso terapéutico , Compuestos de Plata , Factores de Tiempo , Decoloración de Dientes/inducido químicamente
4.
J Comp Neurol ; 498(5): 581-92, 2006 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-16917821

RESUMEN

Vesicular glutamate transporters (VGLUT1, -2, and -3) mediate the accumulation of transmitter glutamate into synaptic vesicles in glutamatergic neurons. VGLUT1 and VGLUT2 are more reliable glutamatergic neuron markers, since VGLUT3 also exists in other neuron types. To study whether the dopaminergic neuron uses glutamate as a cotransmitter, we analyzed VGLUTs expression in dopamine neurons of adult male rats by in situ hybridization and immunohistochemistry. In the ventral midbrain, in situ hybridization analysis revealed no VGLUT1 mRNA expression, a widespread but discrete pattern of VGLUT2 mRNA expression, and a highly limited expression of VGLUT3 mRNA. Reverse-transcriptase polymerase chain reaction analysis detected full-length VGLUT2 gene transcripts in the ventral midbrain. Using in situ hybridization combined with tyrosine hydroxylase (TH) immunostaining, only VGLUT2 signals were detectable in some TH-labeled neurons of A10 dopamine neuron groups, with the highest incidence (20%) in the rostral linear nucleus of the ventral tegmental area. In the forebrain, VGLUT2 signals were demonstrated in half of the A11 TH-labeled neurons in the hypothalamus. Double-label immunostaining for VGLUT2 and vesicular monoamine transporter 2 or TH showed that double-labeled varicosities are rarely observed in any target regions examined of A10 and A11 dopamine neuron groups. These results indicate that VGLUT2 is expressed in subsets of A10 and A11 dopamine neurons, which might release dopamine and glutamate separately from different varicosities in the majority of their single axons.


Asunto(s)
Dopamina/metabolismo , Expresión Génica/fisiología , Hipotálamo/citología , Mesencéfalo/citología , Neuronas/metabolismo , Proteína 2 de Transporte Vesicular de Glutamato/metabolismo , Animales , Northern Blotting/métodos , Recuento de Células/métodos , Inmunohistoquímica/métodos , Hibridación in Situ/métodos , Masculino , Mesencéfalo/metabolismo , Neuronas/clasificación , Ratas , Ratas Sprague-Dawley , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Tirosina 3-Monooxigenasa/metabolismo , Proteínas de Transporte Vesicular de Monoaminas/metabolismo
5.
Am J Dent ; 19(4): 248-52, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16939033

RESUMEN

PURPOSE: To evaluate the occluding ability of ammonium hexafluorosilicate (SiF). METHODS: Dentin disks prepared from human extracted teeth were grouped as follows to prepare different situations of dentin hypersensitivity: (1) those sonicated for 20 minutes; (2) those treated with 0.5 mol/L EDTA for 2 minutes; (3) those treated with 6% citric acid for 2 minutes; (4) those treated with 50% citric acid for 2 minutes. Then, SiF or diamine silver fluoride (AgF) was applied to the dentin disks and the dentin tubule occlusion was observed with scanning electron microscopy (SEM). The percent of open tubules before and after SiF or AgF treatment were measured by NIH image using SEM photographs. Also, the dentin permeability was measured. RESULTS: SEM micrographs demonstrated that the dentin tubules were completely occluded by the precipitate after SiF treatment. Also, the dentin permeability was reduced to 10.3%. In contrast, most of the dentin tubules remained open after AgF treatment. EDXA analysis showed that the precipitate in the dentin tubules that forms after SiF treatment contains Si, Ca and P, indicating a silica-calcium phosphate complex.


Asunto(s)
Permeabilidad de la Dentina/efectos de los fármacos , Sensibilidad de la Dentina/tratamiento farmacológico , Dentina/efectos de los fármacos , Fluoruros/farmacología , Ácido Silícico/farmacología , Ácidos/farmacología , Adulto , Análisis de Varianza , Ácido Cítrico/farmacología , Dentina/ultraestructura , Ácido Edético/farmacología , Humanos
6.
Eur J Neurosci ; 22(3): 672-80, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16101749

RESUMEN

A second vesicular glutamate transporter (VGLUT2) has been reported to be expressed in neurosecretory neurons of the hypothalamic-neurohypophysial system. To study its role in the neurosecretory neurons, we evaluated the expression of the VGLUT2 gene in the paraventricular (PVN) and supraoptic (SON) nuclei as well as the immunoreactivity in the neurohypophysis under euhydrated and chronic hyperosmotic conditions with in situ hybridization and immunohistochemistry. The intensity of hybridization signals in the PVN, SON and thalamus of rats subjected to water deprivation for 7 days, or drinking 2% NaCl for 4 or 7 days, was compared with that of euhydrated rats (control). The overall intensity in the entire PVN or SON, but not the thalamus, was higher in osmotically stimulated rats than in controls. Within the PVN, a significantly higher intensity of signals than that of controls was found only in the dorsolateral posterior magnocellular region in 4-day salt-loaded rats and in all subregions in water-deprived or 7-day salt-loaded rats. The intensity in the SON was higher in the stimulated rats than in controls, regardless of subregions. In the neurohypophysis, VGLUT2 staining was frequently localized in vasopressin terminals of control rats and was apparently reduced in stimulated rats. These results indicate that VGLUT2 is principally expressed in magnocellular vasopressin neurons, suggesting some local effect of intrinsic glutamate on neurohypophysial hormone secretion.


Asunto(s)
Hipotálamo/citología , Proteínas de Transporte de Membrana/metabolismo , Neuronas/metabolismo , Neurohipófisis/metabolismo , Animales , Hipotálamo/metabolismo , Inmunohistoquímica/métodos , Hibridación in Situ/métodos , Masculino , Glicoproteínas de Membrana/metabolismo , Proteínas de Transporte de Membrana/genética , Concentración Osmolar , Presión Osmótica , Estimulación Física/métodos , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Regulación hacia Arriba , Vasopresinas/metabolismo , Proteína 2 de Transporte Vesicular de Glutamato , Privación de Agua/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA